<unk>  is a procedure in which biomarkers (for example, biological molecules or changes in tumor cell DNA) are used to estimate a person's risk for developing cancer. Specific biomarkers may be linked to particular types of cancer.
Molecular risk assessment
Point-of-care genetic testing
Risk panel
Magnetogenetics
Integrated cognitive assessment
Carrier testing
Monitoring in clinical trials
Pharmacomicrobiomics